What is the primary treatment for toxoplasmosis in pregnant women?

The primary treatment for toxoplasmosis in pregnant women is spiramycin. This antibiotic is specifically used to reduce the risk of vertical transmission of Toxoplasma gondii from the mother to the fetus. Spiramycin is preferred during pregnancy because it is considered safer for the fetus compared to other treatments that may have more significant side effects.

In cases where there is evidence of severe infection or if the fetus is at high risk, more aggressive treatment may be warranted, which can include pyrimethamine. However, pyrimethamine could potentially have adverse effects on the fetus, leading healthcare providers to favor spiramycin for managing toxoplasmosis in pregnancy. Therefore, the focus during antenatal care is often on preventing transmission, and spiramycin is effective for that purpose.